WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

In this article, we are going to take a look at where Kiniksa Pharmaceuticals International ... interesting developments for the UK market. The main stock market index has increased 5.86% since ...

Marksans Pharma shares rose over 4% after its Goa plant secured Australian TGA approval for solid dosage forms. Its UK arm ...

On Tuesday, trading of Hepion Pharmaceuticals’ common stock continued on The Nasdaq Capital Market ... with Laidlaw & Company (UK) Ltd. acting as the sole placement agent. In financial disclosures, ...

On Friday, Cantor Fitzgerald reiterated its Overweight rating on aTyr Pharma (NASDAQ:ATYR) stock, with a focus on the company’s leading drug, Efzofitimod (Efzo; NRP2 modulator). The company, currently ...

Tokyo, Japan and Cambridge, UK, 25 March 2025 - Nxera Pharma Co., Ltd. ("Nxera" or "the Company"; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a pot ...

The Association of the British Pharmaceutical Industry is the trade ... Price Action: NVO stock is up 4.23% at $80.41 at the last check on Monday.

On Wednesday, Madrigal Pharmaceuticals, Inc. (NASDAQ ... and are well positioned for strong performance again in 2025 and beyond." Price Action: MDGL stock is up 20.30% at $372.26 at the last check on ...

US stocks rose for a third day in a row despite souring consumer confidence — and as investors weighed whether President ...

Verona Pharma plc (NASDAQ:VRNA) plans to introduce Ohtuvayre to the EU and UK markets and continue developments ... If you are looking for an AI stock that is more promising than VRNA but that ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time ...